Skip to main content
Equibles
LUCD logo

LUCD · Lucid Diagnostics Inc.

Track LUCD — free

Use LUCD with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about LUCD

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.96 +0.00 (+0.41%) At close · Aug 21
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date the accompanying unaudited condensed consolidated financial statements are issued.”
View the 10-Q filed Aug 12, 2026
Market Cap
$196.46M
Shares
203.24M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$0.96 Open$0.97 Day$0.94–0.98 52W close$0.87–1.47 Avg vol 30d1.3M Short int12.1M · 6.0% float · 8.3d Short vol62% Last earningsAug 13, 2026 DataOct 2021–Aug 2026 Filing10-Q · Aug 12

Up next

Next earnings call
Nov 12, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 12, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Neutral Momentum Weak Sentiment Neutral Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 15.1 · calm Equity put/call 0.58
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −14%
      below
      Price vs 50-day avg −3%
      below
      RSI (14) 49
      neutral
      MACD trend Positive
      52-week position 15%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return +6%
      trailing
      6-month return −34%
      trailing
      YTD return −12%
      this year
      Relative strength −45%
      vs S&P · 6-mo
      Sentiment
      smart money
      Neutral
      Trend (MA cross) No cross
      50d $1 › 200d $1 — 200d above 50d
      Institutional flow Accumulating
      +12% holders QoQ · +25 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      5.97% of float · ▲ +11.3% MoM · 8.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      115 holders — near 3-yr high, broad support
      Squeeze score 66
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth +79%
      Y/Y
      Gross margin 9%
      contracting
      EPS growth +17%
      Y/Y
      Free cash flow $-46.7M
      Balance sheet $9.1M
      net cash
      Quant / Vol
      risk profile
      Very High
      Volatility 66%
      annualized · 1-yr
      Max drawdown −41%
      past year
      ATR 5.5%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 5 · 1
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −14% Bearish
      Price vs 50-day avg
      −3% Neutral
      RSI (14)
      49 Neutral
      MACD trend
      Positive Bullish
      52-week position
      15% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bullish · 2 of 6
      Trend (MA cross) No cross
      50d $1 › 200d $1 — 200d above 50d
      Institutional flow Accumulating
      +12% holders QoQ · +25 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      5.97% of float · ▲ +11.3% MoM · 8.3 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Multi-yr high
      115 holders — near 3-yr high, broad support
      Price context
      position in its 52-week range
      Range low $1 Now $1 · 15% Range high $1
      vs 200-day avg -14% vs 50-day avg -3%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Non-GAAP adjusted (loss) income per share non-GAAP -$0.06 three months ended June 30, 2026 —

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Medical Devices — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      LUCD
      Lucid Diagnostics Inc.
      this stock
      		$196.46M -11.5% +79.0% — 6.0%
      ABT
      Abbott Laboratories
      		 $198.81B -6.9% +5.7% 32.0 1.3%
      SYK
      Stryker Corp
      		 $126.37B -6.3% +11.2% 34.1 2.2%
      MDT
      Medtronic plc
      		 $119.47B -2.8% +8.4% 25.0 1.4%
      BSX
      Boston Scientific Corp
      		 $71.55B -47.2% +12.5% 20.0 1.5%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      115
      % held
      30.3%
      Net QoQ
      +25.9M sh
      Top holder
      Alyeska Investment Group,…
      Held Float
      View
      Held by Funds
      Fund positions
      76
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      12.1M
      Days to cover
      8.3d
      Change
      +1.2M sh
      View
      Short Volume
      Short vol %
      62%
      As of
      Aug 21, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      6.6K
      Value
      $6.3K
      As of
      Jul 20, 2026
      View
      Off-Exchange
      Off-exchange %
      59.6%
      Week of
      Jul 13, 2026
      Off-exch Lit
      View
      Financials
      Financials
      Revenue (FY)
      $4.3M
      Net income (FY)
      $-58.0M
      EPS diluted
      $-1.05
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 13, 2026
      This year
      12
      View
      Proposed Sales
      Value
      $49.1K
      Shares
      33.9K
      Filed
      Sep 26, 2023
      View
      Exempt Offerings
      Offering
      $22.0M
      Filed
      Dec 6, 2024
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 13, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      LUCD -0.4% +6.2% -33.5% +10.6% -11.5%
      SPY -1.4% +3.6% +11.6% +2.5% +12.3%
      vs SPY +1.0% +2.6% -45.1% +8.1% -23.8%
      Key facts CIK 1799011 CUSIP 54948X109 13F (30d) 103 filings 103 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)